Lesley Probert

Title: Lesley Probert: Innovator in Neurological Treatments

Introduction

Lesley Probert is a notable inventor based in Athens, Greece. He has made significant contributions to the field of neurological disease treatment, holding 2 patents that reflect his innovative approach to medical science.

Latest Patents

Probert's latest patents include groundbreaking methods for treating neurological disorders. One patent focuses on a method that involves peripheral administration of a DN-TNF polypeptide, which inhibits the activity of soluble TNF- but not transmembrane TNF-α. Another patent describes conjugates that comprise mannan and myelin oligodendrocyte glycoprotein (MOG). This invention includes a conjugate featuring mannan linked to an epitope comprising a peptide fragment of proteins such as myelin basic protein (MBP), MOG, and proteolipid protein (PLP). These conjugates are designed for use in pharmaceutical compositions aimed at treating immune disorders.

Career Highlights

Throughout his career, Lesley Probert has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notable among these are Xencor, Inc. and Vianex S.A. His work has significantly advanced the understanding and treatment of neurological diseases.

Collaborations

Probert has collaborated with esteemed colleagues, including David Szymkowski and Malu Lourdes Tansey. These partnerships have fostered innovation and contributed to the development of effective treatments in his field.

Conclusion

Lesley Probert's contributions to the treatment of neurological diseases through his patents and collaborations highlight his role as a leading inventor in the medical field. His work continues to inspire advancements in healthcare and therapeutic solutions.